NASDAQ$GRAL
Grail Inc · Q3 2025 earnings
Q3 2025 earnings · · After market close · Investor relations
Briefing
GRAL reported Q3 2025 revenue of $36.2M, a net loss of $89.0M.
For Q3 2025, GRAL reported Revenue was $36.2M, net loss was $89.0M. The filing discusses operating performance, liquidity, and outlook in MD&A.
- Revenue $36.2M for Q3 2025.
- Net loss $89.0M.
- MD&A covers R&D, cash runway, and sector-specific risks.
Headline financials
Revenue & EPS history
Grail Inc · Revenue · Quarterly
$36.2M
Revenue by segment
Grail Inc · $26.7M total across 2 segments · Q1 2024
- Screening revenue$23.5M—88.1%
- Development services$3.18M—11.9%
Forward guidance
Outlook focuses on cash runway, pipeline milestones, and cost discipline as the company works toward profitability.
Tailwinds
- Cash and equivalents support operations into upcoming milestones.
- Clinical or product pipeline progress noted in MD&A.
Headwinds
- Ongoing operating losses and R&D spend pressure near-term earnings.
- Financing, dilution, or partnership timing may affect liquidity.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 8 quarterly earnings reports · overlaid with Q3 2025
-4.0%
Avg return
Earnings day
-0.4%
Avg return
5 days after
+4.5%
Avg return
30 days after
50%
4 / 8 earnings
Positive
+4.8%
Q3 2023
Best reaction
-23.6%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.8% | +12.5% | +10.2% | |
| Q3 2025 | -1.9% | -3.9% | +7.1% | |
| Q1 2025 | -23.6% | -10.9% | -3.7% | |
| Q4 2024 | -14.7% | -8.1% | -36.6% | |
| Q3 2023 | +4.8% | -7.2% | +46.9% | |
| Q3 2024 | +4.1% | -3.3% | +35.8% | |
| Q2 2023 | +0.1% | +9.0% | -11.8% | |
| Q2 2024 | +0.1% | +9.0% | -11.8% | |
| Q1 2024 | — | — | — | |
| Q4 2023 | — | — | — | |
| Q1 2023 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q3 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro